The technology generates a visual flowchart with the potential causes and effects of diseases to find new cures.

Created by the London-based company, which also has an office in Athens, it has received £750,000 in funding to date, and has partnered with the likes of Harvard University and the University College London's School of Pharmacy.

See more of our 51 AI Innovators here.